Vitrafy Life Sciences Limited | Suite 2, Level 11, 385 Bourke Street Melbourne VIC 3000| ABN 48 622 720 254 T +61 3 4331 9974 | W www.vitrafy.com | E investors@vitrafy.com ASX ANNOUNCEMENT 3 August 2026 Vitrafy Life Sciences – FY26 Annual Results Investor Briefing ...
Vitrafy FY26 Investor Briefing
Filed with ASX ·
6ix hasn’t read this filing yet.
Vitrafy Life Sciences Ltd. on 6ix
In the deck
Earlier from Vitrafy Life Sciences
- Q4 FY26 Quarterly Activities Report and Appendix 4C
- Vitrafy enters a partnership with Hoxworth Blood Center
- Vitrafy Share Purchase Plan Opens - SPP Offer Booklet
- Vitrafy Placement Completion and SPP Announcement
- Vitrafy Equity Raising Presentation
Later from Vitrafy Life Sciences
- FY26 Appendix 4G
- FY26 Corporate Governance Statement
- FY26 Appendix 4E and Annual Report
- FY26 Full Year Results Presentation
- Vitrafy enters U.S. Cell & Gene Therapy Market
Follow Vitrafy Life Sciences into a list and get an email when it puts out news.
Follow Vitrafy Life Sciences